CRISPR/Cas9 Delivery Potentials in Alzheimer's Disease Management: A Mini Review
Alzheimer's disease (AD) is the most common dementia disorder. While genetic mutations account for only 1% of AD cases, sporadic AD resulting from a combination of genetic and risk factors constitutes >90% of the cases. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-assoc...
Saved in:
Main Authors: | Amira Sayed Hanafy (Author), Susanne Schoch (Author), Alf Lamprecht (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CRISPR/Cas9 systems: Delivery technologies and biomedical applications
by: Yimin Du, et al.
Published: (2023) -
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
by: Matthew Behr, et al.
Published: (2021) -
CRISPR-Cas9 delivery strategies with engineered extracellular vesicles
by: Yaoyao Lu, et al.
Published: (2023) -
Advances in Chitosan-Based CRISPR/Cas9 Delivery Systems
by: Anna E. Caprifico, et al.
Published: (2022) -
Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment
by: Meng Lin, et al.
Published: (2023)